{"id":2416,"date":"2021-01-24T00:00:00","date_gmt":"2021-01-24T05:00:00","guid":{"rendered":"https:\/\/icesontario.wpengine.com\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/"},"modified":"2023-06-14T19:37:28","modified_gmt":"2023-06-14T23:37:28","slug":"opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery","status":"publish","type":"journal_article","link":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/","title":{"rendered":"Opioid prescribing practices for women undergoing elective gynecologic surgery"},"content":{"rendered":"<p><strong>Study Objective <\/strong>&#x2014; To describe the opioid prescribing practices in opioid-na&#xef;ve women undergoing elective gynecologic surgery for benign indications and identify risk factors associated with increased perioperative opioid use. We also explored factors associated with new persistent opioid use in women with perioperative opioid use.<\/p>\n<p><strong>Design <\/strong>&#x2014; Retrospective, population-based cohort study.<\/p>\n<p><strong>Setting <\/strong>&#x2014; We used linked administrative data from a government-administered single-payer provincial healthcare system in Canada. This study was undertaken at ICES, a not-for-profit research institute in Ontario, Canada.<\/p>\n<p><strong>Patients <\/strong>&#x2014; We followed opioid-na&#xef;ve adult women who underwent benign elective gynecologic surgery between 2013 and 2018.<\/p>\n<p><strong>Interventions <\/strong>&#x2014; None<\/p>\n<p><span class=\"bold\">Measurements and Main Results<\/span> &#x2014; The primary outcome was peri-operative opioid use defined as &#x2265;1 opioid prescription from 30 days before to 14 days after surgery. New persistent opioid use after gynecologic surgery was defined as having filled 1 or more opioid prescriptions between 91 days to 180 days postoperatively. Multivariable log-linear regression analyses were employed to adjust for clinical and demographic data.<\/p>\n<p>Of the 132 506 patients included in our cohort, most (74.3%) underwent minor gynecologic procedures. Perioperative opioid use was documented in 27 763 (21.0%) patients, and there was a significant decreasing trend (p &lt;.001) in the proportion of patients with perioperative opioid use from 21.8% in 2013 to 18.5% in 2018. Factors associated with increased perioperative opioid use included younger age; higher income quintile; urban dwellers; and diagnosis of infertility, endometriosis, or adnexal mass. Perioperative opioid use was an independent risk factor for persistent use (adjusted relative risk 1.40; 95% confidence interval, 1.13&#x2013;1.72) and for every 65 patients prescribed opioids associated with gynecologic surgery, one developed new persistent opioid use. The highest risk factor for developing persistent use was filling a high-dose opioid prescription (adjusted relative risk<sub>5th quintileOME<\/sub> 2.33; 95% confidence interval, 1.83&#x2013;2.96).<\/p>\n<p><strong>Conclusion<\/strong> &#x2014; One in 5 women who undergo a gynecologic procedure has a new exposure to opioids. For every 65 patients who fill an opioid prescription after their gynecologic surgery, one will experience prolonged opioid use.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Study Objective &#x2014; To describe the opioid prescribing practices in opioid-na&#xef;ve women undergoing elective gynecologic surgery for benign indications and identify risk factors associated with increased perioperative opioid use. We also explored factors associated with new persistent opioid use in women with perioperative opioid use. Design &#x2014; Retrospective, population-based cohort study. Setting &#x2014; We used [&hellip;]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[],"migration-helper-qa-sample-set":[],"class_list":["post-2416","journal_article","type-journal_article","status-publish","hentry"],"acf":{"citation":"Chan WV, Le B, Lam M, Shariff SZ, Gomes T, Lipscombe L, Murji A. <em>J Minim Invasive Gynecol<\/em>. 2021; 28(7):1325-33.e3. Epub 2021 Jan 24.","source_url":"https:\/\/www.jmig.org\/article\/S1553-4650(21)00044-3\/fulltext","ices_scientist":[1359,1295,1252],"site":[6739],"research_program":[6746],"news_release":[],"journal_article":[],"atlas":[],"research_report":[],"infographic":[],"video":[],"downloads":null,"links":null,"sitecore_item_id":"9FA6706E-915D-4D60-9F3F-575F315BE5E5","sitecore_item_name":"Opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery","sitecore_field_values":"{\n  \"Title\": \"Opioid prescribing practices for women undergoing elective gynecologic surgery\",\n  \"Short title\": \"Opioid prescribing practices for women\",\n  \"Summary\": \"This study aimed to describe the opioid prescribing practices in opioid-na\u00efve women undergoing elective gynecologic surgery for benign indications.\",\n  \"Citation\": \"<p>Chan WV, Le B, Lam M, Shariff SZ, Gomes T, Lipscombe L, Murji A. <em>J Minim Invasive Gynecol<\/em>. 2021; 28(7):1325-33.e3. Epub 2021 Jan 24. DOI: <a href=\"https:\/\/doi.org\/10.1016\/j.jmig.2021.01.011\" title=\"Opens external link\">https:\/\/doi.org\/10.1016\/j.jmig.2021.01.011<\/a><\/p>\",\n  \"Abstract\": \"<p><strong>Study Objective <\/strong>&mdash; To describe the opioid prescribing practices in opioid-na&iuml;ve women undergoing elective gynecologic surgery for benign indications and identify risk factors associated with increased perioperative opioid use. We also explored factors associated with new persistent opioid use in women with perioperative opioid use.<\/p>n<p><strong>Design <\/strong>&mdash; Retrospective, population-based cohort study.<\/p>n<p><strong>Setting <\/strong>&mdash; We used linked administrative data from a government-administered single-payer provincial healthcare system in Canada. This study was undertaken at ICES, a not-for-profit research institute in Ontario, Canada.<\/p>n<p><strong>Patients <\/strong>&mdash; We followed opioid-na&iuml;ve adult women who underwent benign elective gynecologic surgery between 2013 and 2018.<\/p>n<p><strong>Interventions <\/strong>&mdash; None<\/p>n<p><span class=\"bold\">Measurements and Main Results<\/span> &mdash; The primary outcome was peri-operative opioid use defined as &ge;1 opioid prescription from 30 days before to 14 days after surgery. New persistent opioid use after gynecologic surgery was defined as having filled 1 or more opioid prescriptions between 91 days to 180 days postoperatively. Multivariable log-linear regression analyses were employed to adjust for clinical and demographic data.<\/p>n<p>Of the 132 506 patients included in our cohort, most (74.3%) underwent minor gynecologic procedures. Perioperative opioid use was documented in 27 763 (21.0%) patients, and there was a significant decreasing trend (p &lt;.001) in the proportion of patients with perioperative opioid use from 21.8% in 2013 to 18.5% in 2018. Factors associated with increased perioperative opioid use included younger age; higher income quintile; urban dwellers; and diagnosis of infertility, endometriosis, or adnexal mass. Perioperative opioid use was an independent risk factor for persistent use (adjusted relative risk 1.40; 95% confidence interval, 1.13&ndash;1.72) and for every 65 patients prescribed opioids associated with gynecologic surgery, one developed new persistent opioid use. The highest risk factor for developing persistent use was filling a high-dose opioid prescription (adjusted relative risk<sub>5th quintileOME<\/sub> 2.33; 95% confidence interval, 1.83&ndash;2.96).<\/p>n<p><strong>Conclusion<\/strong> &mdash; One in 5 women who undergo a gynecologic procedure has a new exposure to opioids. For every 65 patients who fill an opioid prescription after their gynecologic surgery, one will experience prolonged opioid use.<\/p>n<p><a href=\"https:\/\/www.jmig.org\/article\/S1553-4650(21)00044-3\/fulltext\" title=\"Opens external link\">View full text<\/a><\/p>\",\n  \"Research Programs\": \"{CFE36C89-C969-4C23-B5E4-1BA9E5BDC273}\",\n  \"ICES Locations\": \"{3B4AF7E8-6835-410B-AEB8-360A79CA0ED8}\",\n  \"ICES Scientists\": \"{E8DA0CD3-1341-4EA5-846D-D3FCFCEB3137}|{DC2C9ADE-ED70-4834-A8AC-A7271C6E48F5}|{1FA4634A-81DF-4A25-8739-98ABF3872B45}\",\n  \"Posted Date\": \"20210124T000000\",\n  \"Show on Publications Landing Page\": \"1\"\n}","previous_url":"https:\/\/www.ices.on.ca\/Publications\/Journal-Articles\/2021\/January\/Opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICES | Opioid prescribing practices for women undergoing elective gynecologic surgery<\/title>\n<meta name=\"description\" content=\"Study Objective &#x2014; To describe the opioid prescribing practices in opioid-na&#xef;ve women undergoing elective gynecologic surgery for benign\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | Opioid prescribing practices for women undergoing elective gynecologic surgery\" \/>\n<meta property=\"og:description\" content=\"Study Objective &#x2014; To describe the opioid prescribing practices in opioid-na&#xef;ve women undergoing elective gynecologic surgery for benign\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-14T23:37:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\\\/\",\"name\":\"ICES | Opioid prescribing practices for women undergoing elective gynecologic surgery\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2021-01-24T05:00:00+00:00\",\"dateModified\":\"2023-06-14T23:37:28+00:00\",\"description\":\"Study Objective &#x2014; To describe the opioid prescribing practices in opioid-na&#xef;ve women undergoing elective gynecologic surgery for benign\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal Articles\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Opioid prescribing practices for women undergoing elective gynecologic surgery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | Opioid prescribing practices for women undergoing elective gynecologic surgery","description":"Study Objective &#x2014; To describe the opioid prescribing practices in opioid-na&#xef;ve women undergoing elective gynecologic surgery for benign","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | Opioid prescribing practices for women undergoing elective gynecologic surgery","og_description":"Study Objective &#x2014; To describe the opioid prescribing practices in opioid-na&#xef;ve women undergoing elective gynecologic surgery for benign","og_url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2023-06-14T23:37:28+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/","url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/","name":"ICES | Opioid prescribing practices for women undergoing elective gynecologic surgery","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2021-01-24T05:00:00+00:00","dateModified":"2023-06-14T23:37:28+00:00","description":"Study Objective &#x2014; To describe the opioid prescribing practices in opioid-na&#xef;ve women undergoing elective gynecologic surgery for benign","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/opioid-prescribing-practices-for-women-undergoing-elective-gynecologic-surgery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Journal Articles","item":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/"},{"@type":"ListItem","position":3,"name":"Opioid prescribing practices for women undergoing elective gynecologic surgery"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article\/2416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/journal_article"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/research_program\/6746"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6739"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1252"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1295"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1359"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=2416"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=2416"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=2416"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/topic?post=2416"},{"taxonomy":"migration-helper-qa-sample-set","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-qa-sample-set?post=2416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}